BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Johnson MD, Lewis RE, Dodds Ashley ES, Ostrosky-Zeichner L, Zaoutis T, Thompson GR, Andes DR, Walsh TJ, Pappas PG, Cornely OA, Perfect JR, Kontoyiannis DP. Core Recommendations for Antifungal Stewardship: A Statement of the Mycoses Study Group Education and Research Consortium. J Infect Dis 2020;222:S175-98. [PMID: 32756879 DOI: 10.1093/infdis/jiaa394] [Cited by in Crossref: 21] [Cited by in F6Publishing: 21] [Article Influence: 21.0] [Reference Citation Analysis]
Number Citing Articles
1 Granwehr BP, Kontoyiannis DP. Fungal Infections in Cancer Patients. Encyclopedia of Mycology. Elsevier; 2021. pp. 792-802. [DOI: 10.1016/b978-0-12-819990-9.00043-3] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
2 Gupta AK, Venkataraman M, Renaud HJ, Summerbell R, Shear NH, Piguet V. The increasing problem of treatment-resistant fungal infections: a call for antifungal stewardship programs. Int J Dermatol 2021. [PMID: 33729567 DOI: 10.1111/ijd.15495] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
3 Soulountsi V, Schizodimos T, Kotoulas SC. Deciphering the epidemiology of invasive candidiasis in the intensive care unit: is it possible? Infection 2021. [PMID: 34132989 DOI: 10.1007/s15010-021-01640-7] [Reference Citation Analysis]
4 So M, Hand J, Forrest G, Pouch SM, Te H, Ardura MI, Bartash RM, Dadhania DM, Edelman J, Ince D, Jorgenson MR, Kabbani S, Lease ED, Levine D, Ohler L, Patel G, Pisano J, Spinner ML, Abbo L, Verna EC, Husain S. White paper on antimicrobial stewardship in solid organ transplant recipients. Am J Transplant 2021. [PMID: 34212491 DOI: 10.1111/ajt.16743] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
5 Bienvenu AL, Pradat P, Plesa A, Leclerc V, Piriou V, Fellahi JL, Argaud L, Rimmelé T, Menotti J, Aubrun F, Richard JC, Gagnieu MC, Parant F, Chidiac C, Leboucher G, Tod M, Goutelle S. Association between voriconazole exposure and Sequential Organ Failure Assessment (SOFA) score in critically ill patients. PLoS One 2021;16:e0260656. [PMID: 34818379 DOI: 10.1371/journal.pone.0260656] [Reference Citation Analysis]
6 Johnson MD, Lewis RE, Dodds Ashley ES, Perfect JR, Kontoyiannis DP. Reply to Day et al. J Infect Dis 2021:jiab183. [PMID: 33822103 DOI: 10.1093/infdis/jiab183] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
7 Roth RS, Masouridi-Levrat S, Giannotti F, Mamez AC, Glambedakis E, Lamoth F, Bochud PY, Erard V, Emonet S, Van Delden C, Kaiser L, Chalandon Y, Neofytos D. Frequency and causes of antifungal treatment changes in allogeneic haematopoïetic cell transplant recipients with invasive mould infections. Mycoses 2021. [PMID: 34936143 DOI: 10.1111/myc.13416] [Reference Citation Analysis]
8 Kennedy CC, Pennington KM, Beam E, Razonable RR. Fungal Infection in Lung Transplantation. Semin Respir Crit Care Med 2021;42:471-82. [PMID: 34030208 DOI: 10.1055/s-0041-1729173] [Reference Citation Analysis]
9 Logan C, Martin-Loeches I, Bicanic T. Invasive candidiasis in critical care: challenges and future directions. Intensive Care Med 2020;46:2001-14. [PMID: 32990778 DOI: 10.1007/s00134-020-06240-x] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 3.5] [Reference Citation Analysis]
10 Amanati A, Badiee P, Jafarian H, Ghasemi F, Nematolahi S, Haghpanah S, Hamzavi SS. Impact of antifungal stewardship interventions on the susceptibility of colonized Candida species in pediatric patients with malignancy. Sci Rep 2021;11:14099. [PMID: 34238976 DOI: 10.1038/s41598-021-93421-3] [Reference Citation Analysis]
11 Alegria W, Patel PK. The Current State of Antifungal Stewardship in Immunocompromised Populations. J Fungi (Basel) 2021;7:352. [PMID: 33946217 DOI: 10.3390/jof7050352] [Reference Citation Analysis]
12 Di Paolo M, Hewitt L, Nwanko E, Ni M, Vidal-Diaz A, Fisher MC, Armstrong-James D, Shah A. A retrospective 'real-world' cohort study of azole therapeutic drug monitoring and evolution of antifungal resistance in cystic fibrosis. JAC Antimicrob Resist 2021;3:dlab026. [PMID: 34223100 DOI: 10.1093/jacamr/dlab026] [Reference Citation Analysis]
13 Prusakov P, Goff DA, Wozniak PS, Cassim A, Scipion CEA, Urzúa S, Ronchi A, Zeng L, Ladipo-Ajayi O, Aviles-Otero N, Udeigwe-Okeke CR, Melamed R, Silveira RC, Auriti C, Beltrán-Arroyave C, Zamora-Flores E, Sanchez-Codez M, Donkor ES, Kekomäki S, Mainini N, Trochez RV, Casey J, Graus JM, Muller M, Singh S, Loeffen Y, Pérez MET, Ferreyra GI, Lima-Rogel V, Perrone B, Izquierdo G, Cernada M, Stoffella S, Ekenze SO, de Alba-Romero C, Tzialla C, Pham JT, Hosoi K, Consuegra MCC, Betta P, Hoyos OA, Roilides E, Naranjo-Zuñiga G, Oshiro M, Garay V, Mondì V, Mazzeo D, Stahl JA, Cantey JB, Monsalve JGM, Normann E, Landgrave LC, Mazouri A, Avila CA, Piersigilli F, Trujillo M, Kolman S, Delgado V, Guzman V, Abdellatif M, Monterrosa L, Tina LG, Yunis K, Rodriguez MAB, Saux NL, Leonardi V, Porta A, Latorre G, Nakanishi H, Meir M, Manzoni P, Norero X, Hoyos A, Arias D, Sánchez RG, Medoro AK, Sánchez PJ; Global NEO-ASP Study Group. A global point prevalence survey of antimicrobial use in neonatal intensive care units: The no-more-antibiotics and resistance (NO-MAS-R) study. EClinicalMedicine 2021;32:100727. [PMID: 33554094 DOI: 10.1016/j.eclinm.2021.100727] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
14 Jain N, Jansone I, Obidenova T, Sīmanis R, Meisters J, Straupmane D, Reinis A. Epidemiological Characterization of Clinical Fungal Isolates from Pauls Stradinš Clinical University Hospital, Latvia: A 4-Year Surveillance Report. Life (Basel) 2021;11:1002. [PMID: 34685374 DOI: 10.3390/life11101002] [Reference Citation Analysis]
15 Durand C, Maubon D, Cornet M, Wang Y, Aldebert D, Garnaud C. Can We Improve Antifungal Susceptibility Testing? Front Cell Infect Microbiol 2021;11:720609. [PMID: 34568095 DOI: 10.3389/fcimb.2021.720609] [Reference Citation Analysis]
16 Omosa-Manyonyi GS, Koyio LN, Mwangi EW, Gathura H, van der Ven A, Oever JT. Inadequacies in service delivery for the diagnosis and treatment of vaginitis and vaginosis in Nairobi, Kenya. Int J STD AIDS 2022;33:584-96. [PMID: 35380482 DOI: 10.1177/09564624221087533] [Reference Citation Analysis]
17 Khanina A, Cairns KA, Kong DCM, Thursky KA, Slavin MA, Roberts JA. The impact of pharmacist‐led antifungal stewardship interventions in the hospital setting: a systematic review. J Pharm Pract Res 2021;51:90-105. [DOI: 10.1002/jppr.1721] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
18 Berg DM, Slish JC, Wright M, Gandhi AD, Gandhi MA. Current Utilization of Antifungal Agents for Intra-abdominal Infections Categorized by Patient Risk Factors During Surgical Procedures: A Literature Review. J Pharm Pract 2022;:8971900221108716. [PMID: 35705106 DOI: 10.1177/08971900221108716] [Reference Citation Analysis]
19 Hand JM. The time is now: antimicrobial stewardship in solid organ transplantation. Curr Opin Organ Transplant 2021;26:405-11. [PMID: 34039881 DOI: 10.1097/MOT.0000000000000886] [Reference Citation Analysis]
20 Giacobbe DR, Magnasco L, Sepulcri C, Mikulska M, Koehler P, Cornely OA, Bassetti M. Recent advances and future perspectives in the pharmacological treatment of Candida auris infections. Expert Rev Clin Pharmacol 2021;:1-16. [PMID: 34176393 DOI: 10.1080/17512433.2021.1949285] [Reference Citation Analysis]
21 Kidd SE, Crawford LC, Halliday CL. Antifungal Susceptibility Testing and Identification. Infect Dis Clin North Am 2021;35:313-39. [PMID: 34016280 DOI: 10.1016/j.idc.2021.03.004] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
22 Monday LM, Parraga Acosta T, Alangaden G. T2Candida for the Diagnosis and Management of Invasive Candida Infections. J Fungi (Basel) 2021;7:178. [PMID: 33802391 DOI: 10.3390/jof7030178] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
23 Chammas M, Abdul Jawad K, Saberi RA, Gilna G, Urrechaga EM, Cioci A, Rattan R, Pust GD, Namias N, Yeh DD. Role of Empiric Antifungal Therapy in Patients with Perforated Peptic Ulcers. Surg Infect (Larchmt) 2022. [PMID: 35021885 DOI: 10.1089/sur.2021.286] [Reference Citation Analysis]
24 Janssen NAF, Brüggemann RJM, Reijers MH, Henriet SSV, Ten Oever J, de Mast Q, Berk Y, de Kort EA, Kullberg BJ, Netea MG, Buil JB, Rahamat-Langendoen JC, Bury D, Muilwijk EW, Meis JF, Verweij PE, van de Veerdonk FL. A Multidisciplinary Approach to Fungal Infections: One-Year Experiences of a Center of Expertise in Mycology. J Fungi (Basel) 2020;6:E274. [PMID: 33182621 DOI: 10.3390/jof6040274] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.5] [Reference Citation Analysis]
25 Russell Day H, Bond JB, Gupta B, Saeed K, Breazzano MP. Should Routine Eye Examinations Be Included in Treatment Bundles for Patients with Candidemia? The Journal of Infectious Diseases 2021. [DOI: 10.1093/infdis/jiab182] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
26 Keighley C, Cooley L, Morris AJ, Ritchie D, Clark JE, Boan P, Worth LJ; the Australasian Antifungal Guidelines Steering Committee. Consensus guidelines for the diagnosis and management of invasive candidiasis in haematology, oncology and intensive care settings, 2021. Internal Medicine Journal 2021;51:89-117. [DOI: 10.1111/imj.15589] [Reference Citation Analysis]
27 Grau S, Hernández S, Echeverría-Esnal D, Almendral A, Ferrer R, Limón E, Horcajada JP; Catalan Infection Control and Antimicrobial Stewardship Program (VINCat-PROA). Antimicrobial Consumption among 66 Acute Care Hospitals in Catalonia: Impact of the COVID-19 Pandemic. Antibiotics (Basel) 2021;10:943. [PMID: 34438993 DOI: 10.3390/antibiotics10080943] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
28 Beck KR, Odermatt A. Antifungal therapy with azoles and the syndrome of acquired mineralocorticoid excess. Mol Cell Endocrinol 2021;524:111168. [PMID: 33484741 DOI: 10.1016/j.mce.2021.111168] [Reference Citation Analysis]
29 Borman AM, Fraser M, Patterson Z, McLachlan S, Palmer MD, Mann C, Oliver D, Brown P, Linton CJ, Dzietczyk A, Hedley M, Gough M, Zapata L, North P, Johnson EM. Fungal biomarker testing turn-around-times at the UK National Mycology Reference Laboratory: Setting the record straight. J Infect 2021:S0163-4453(21)00509-0. [PMID: 34687830 DOI: 10.1016/j.jinf.2021.10.010] [Reference Citation Analysis]
30 Helweg-Larsen J, Steensen M, Møller Pedersen F, Bredahl Jensen P, Perch M, Møller K, Riis Olesen B, Søderlund M, Cavling Arendrup M. Intensive Care Antifungal Stewardship Programme Based on T2Candida PCR and Candida Mannan Antigen: A Prospective Study. J Fungi (Basel) 2021;7:1044. [PMID: 34947026 DOI: 10.3390/jof7121044] [Reference Citation Analysis]